SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001123292-17-001439
Filing Date
2017-09-21
Accepted
2017-09-21 15:54:05
Documents
1
Period of Report
2017-07-10

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 3951
  Complete submission text file 0001123292-17-001439.txt   5292
Mailing Address 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046
Business Address 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046 443-545-1819
OSIRIS THERAPEUTICS, INC. (Issuer) CIK: 0001360886 (see all company filings)

IRS No.: 710881115 | State of Incorp.: MD | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046
Business Address
Palczuk Linda (Reporting) CIK: 0001717580 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32966 | Film No.: 171095814